Tag:
diabetes
Latest Headlines
Latest Headlines
FDA convenes hospital glucose sensor summit
The FDA i s convening a day-long, public meeting on June 25, where they want clinicians, researchers, government regulators, the device industry clinical laboratories and others to chime in about the best way to develop clinical validation studies for and judge the performance of diabetes devices.
UPDATED: Mobile apps could rival pharma's crown jewels
As we pack more data about our health into mobile devices, pharma companies could face a new competitive threat to their drugs: Mobile health apps.
D. Medical signs worldwide marketing deal for insulin-delivery tech
Israel's D. Medical has signed an original equipment manufacturer agreement with a Korean firm to market its insulin-delivery technology.
D. Medical eyes world stage for insulin infusion device
D. Medical is looking to take its insulin infusion set worldwide, inking a deal with South Korea's Twobiens to market the Spring universal infusion set around the globe.
Report: Bayer contemplates sale of blood glucose meter business
This just in: Bayer is reportedly talking with potential buyers of its blood glucose meters business.
Hygieia releases study results for its new handheld insulin device
Hygieia is touting some impressive results for insulin users with either Type 1 or Type 2 diabetes who used the new company's initial product, a handheld device for automatically adjusting...
GI Dynamics' EndoBarrier implanted in first patients, stock soars
GI Dynamics ($GID) has announced that the first patients have undergone treatment in Australia with the company's EndoBarrier therapy, which is used to treat obesity and Type 2 diabetes.
NeuroMetrix seeks 510(k) nod for pain therapy device
NeuroMetrix reached a significant milestone this week. The Waltham, MA, company filed its 510(k) application with the FDA for its Sensus pain therapy device.
Report: Diabetes Dx market to hit $32B by 2017
Global Industry Analysts predicts that the global diabetes diagnostics market will reach $32 billion by 2017.
Roche helps corral diabetes chitchat from Twitter
The Swiss drug giant is zeroing in on the diabetes community with the recent launch of a page on the social networking site called Diabetes Nest.
